Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/Fluticasone Capsair vs Seretide Diskus in COPD
NCT03363503Phase 4Terminated
- Sponsor
- Neutec Group
- Start
- Apr 2018
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by Neutec Group. Started Apr 2018; status: terminated.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03363503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03363503.